INS and type 1 diabetes mellitus: Together, these results not only show that changes in CHGA continue to reflect alterations in beta cell function over time providing an attractive longitudinal marker, they also demonstrate that with continuous use the beneficial effects of verapamil in subjects with T1D persist for at least 2 years and that verapamil treatment effectively keeps exogenous insulin requirements low.